(MedPage Today) -- Subcutaneous methotrexate can be given at higher doses than in the oral route, while maintaing bioavailability, which could make for better tolerance and better adherence to treatment guidelines, a new study suggested. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment